Effective male birth control for at least 2 years, says the start of biotechnics

Today, almost all available birth control options are female contraceptives. However, the Biotechnical Contraline Company claims that clinical evidence for its non-hormonal and reversible male contraceptive has reached a critical historical moment.

In one announcement Published today, Contraline announced that her male contraceptive, named Adam, proved that she was effective and secure 24 months in the first human clinical test. While their clinical results have not yet been published in a scientific journal, the company plans to issue additional data during the US Urological Association meeting (AUA) on April 26.

Adam is a water-soluble hydrogel injected into the Vasa-Vasa Decrement two tubes to the sperm from the testicles in the urethra-through a small procedure. The implant blocks the sperm as it still allows for spilling, and the contrast has its marketing as a future, long -term alternative, reversible for condoms and vasectomies.

“Our goal was to create a two -year contraceptive male option, responding directly to the needs of the consumer,” said Alexander Pastuszak, Contraline medical chief in release. “These findings confirm that Adam, our water -soluble hydrogel, can achieve the target life expectancy. We remain optimistic about its safety, efficiency and return, and its potential to give men and pairs greater reproductive control.”

Milestone is based on two participants in the first human clinical test showing azoospermia (no sperm in their ejaculation) in 24 months. In one Previous news of the newsContraline claimed that Adam caused a decrease of 99.8% to 100.0% in the number of the driving sperm within 30 days of implantation.

These results “take us a step closer to the transformation of the contraceptive landscape,” said Kevin Eisenfrats, co -founder and CEO of Contraline at the time. They suggest “that it is possible to achieve similar levels of efficiency as long -acting female contraceptives like IUDS. After all, I would like to make Adam a ‘without seeing’ for men when it comes to taking into account their contraception options. “Iuds, or intrauterine equipmentare small female contraceptives inserted into the uterus.

According to the latest news announcement, none of the participants reported seriousor faced unexpected security concerns. Researchers performing the clinical test will continue monitoring other participants in signs 12-, 15-, 18- and 21-month through laboratory and home sperm testing. Moreover, Contrine has received full regulatory approval to start the second phase of the study.

However, Jon Oatley, a professor at the Washington State University Molecular Bioshkes School, stressed that there is no public data yet confirming Adam implant is reversible, and researchers still do not know the long -term effects of Vasa Deferentia blocking, as he said The Guardian. Oatley also suggested that most men would prefer a contraceptive pill or pieces during surgery.

However Data from 2017 to 2019 It indicates that 10.4% of women between the ages of 15 and 49 used long -acting reversible contraceptives, such as IUD or other contraceptive implants that require procedures. This is less than four points after 14%of the pill. If Adam really proves to be safe and effective, perhaps a significant number of men will also choose the long -term efficiency of one injection rather than the short -term benefit of other contraceptives.